General Catalyst

General Catalyst Group Management, LLC is a private equity and venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. The firm specializes in early-stage and growth equity investments, focusing on a wide range of technology sectors, including advanced materials, clean energy, disruptive technology, healthcare IT, and consumer services, among others. General Catalyst typically invests between $0.05 million and $0.25 million in seed-stage companies and between $10 million and $50 million in growth equity, seeking profitable firms with substantial revenue and EBITDA. Their approach emphasizes mentorship and collaboration, fostering strong relationships with entrepreneurs who share their vision and values. They have managed eight venture capital funds, accumulating around $3.75 billion in capital commitments, reflecting their commitment to supporting innovative companies throughout their growth journey.

Adrian Abeijon

Investor

Mark Allen

CFO

Juliet Bailin

Principal

Brian Bedol

Managing Director

Marc Bhargava

Managing Director

Chris Bischoff

Managing Director

Larry Bohn

Managing Director

Kristen Camarota

Investor

Kenneth Chenault

Chairman and Managing Director

Quentin Clark

Managing Director

Mark Crane

Partner, Investment Team

Joel Cutler

Co-Founder and Managing Director

Christopher Davis

Partner, Investments

Kyle Doherty

Managing Director, Investments

Bill Fitzgerald

Co-Founder and Special Advisors

Molly Blaauw Gillis

Partner and Chief of Staff

Jeremy Goldstein

Partner

Julia Goodman

Investor

Drew Gordon

Investor

Steve Herrod

Managing Director

Tony Ho

Investor

Diana Hong

Investor

Mina Hsiang

Associate

Paula Hübner

Partner

Nmachi Jidenma

Partner

Christopher Kauffman

Principal and Member of the Investment Team

Zak Kukoff

Principal

Bill Kung

Principal

Paul Kwan

Managing Director

Alexandre Momeni

Executive, Investments and Partner

Deep Nishar

Managing Director

Dipchand ("Deep") Nishar

Managing Director

Reva Nohria

Principal

Trevor Oelschig

Managing Director

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Max Rimpel

Partner

Paul Sagan

Investor

Pranav Singhvi

Managing Director

Vedant Suri

Investor

Alex Tran

Managing Director

Catherine Tu

Partner

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Vincent Zhu

Investor

Past deals in Dental

Fractyl Health

Series F in 2022
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Sesame

Series B in 2022
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.

Overjet

Series B in 2021
Overjet, Inc. is a software company based in Allston, Massachusetts, specializing in artificial intelligence solutions for the dental industry. Founded in 2018, the company develops a platform that analyzes dental clinical data to enhance the quality of care and reduce costs. Overjet's clinical optimization software evaluates practice performance and identifies areas for growth, while its utilization software facilitates automatic claims reviews to ensure appropriate care delivery. The company's AI engine utilizes computer vision and machine learning algorithms to detect common oral anomalies in X-rays, providing dental providers and payers with tools to improve patient outcomes. By empowering dental organizations, Overjet aims to enable precise pathology detection and enhance patient education in dental care.

Well

Series B in 2021
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

Overjet

Series A in 2021
Overjet, Inc. is a software company based in Allston, Massachusetts, specializing in artificial intelligence solutions for the dental industry. Founded in 2018, the company develops a platform that analyzes dental clinical data to enhance the quality of care and reduce costs. Overjet's clinical optimization software evaluates practice performance and identifies areas for growth, while its utilization software facilitates automatic claims reviews to ensure appropriate care delivery. The company's AI engine utilizes computer vision and machine learning algorithms to detect common oral anomalies in X-rays, providing dental providers and payers with tools to improve patient outcomes. By empowering dental organizations, Overjet aims to enable precise pathology detection and enhance patient education in dental care.

Sesame

Series B in 2021
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.

Well

Series A in 2020
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

Fractyl Health

Series E in 2020
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Sesame

Series A in 2019
Sesame, Inc., operating as SesameCare, is a company that offers a platform for booking doctor appointments and accessing medical care. Founded in 2018 and based in New York, SesameCare aims to simplify the healthcare experience by connecting patients directly with doctors, providing upfront pricing and clear descriptions of medical services. This approach is particularly beneficial for uninsured individuals or those opting to pay out-of-pocket, as it addresses common issues such as hidden costs and unexpected charges that often complicate healthcare access. By focusing on transparency and affordability, SesameCare endeavors to make quality healthcare more accessible for all patients.

Well

Seed Round in 2019
Well Dot, Inc. is a company that specializes in artificial intelligence-driven consumer health engagement through its platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Newton, Massachusetts; New York, New York; and Minneapolis, Minnesota, the company offers personalized health guidance and support to employees by leveraging clinical and consumer data. By integrating advanced artificial intelligence and principles of behavioral economics, Well aims to assist its members in achieving their health goals effectively.

Fractyl Health

Series D in 2017
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Brighter

Series D in 2016
Brighter, Inc. provides a platform that connects patients, providers, and payers. It delivers consumer-driven dental benefits for the employees of self-insured companies, as well as licenses its member and provider engagement platforms to large carriers. Brighter, Inc. was formerly known as Medical and Dental Commerce Corporation and changed its name to Brighter, Inc. in October 2013. The company was incorporated in 2010 and is based in Santa Monica, California. As of December 14, 2017, Brighter, Inc. operates as a subsidiary of Cigna Corporation.

Fractyl Health

Series C in 2015
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.

Fractyl Health

Series B in 2014
Fractyl Health Inc. is a medical device company specializing in innovative therapies for metabolic diseases, particularly type 2 diabetes and obesity. The company's flagship product, Revita DMR, is a minimally invasive procedure that utilizes hydrothermal ablation to rejuvenate the lining of the duodenum, effectively addressing the underlying causes of these conditions. By focusing on transforming the treatment of metabolic diseases from merely managing symptoms to providing durable, disease-modifying solutions, Fractyl Health aims to significantly improve patient health outcomes. Founded in 2010 and based in Lexington, Massachusetts, the company is committed to developing curative therapies that lessen the burden on patients, healthcare providers, and payers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.